News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
Dr. Wilf Keller appointed as the new President and CEO of Genome Prairie

.

Saskatoon, Saskatchewan and Winnipeg, Manitoba, Canada
June 27, 2008

Dr. Arnold Naimark, Chair of Genome Prairie's Board of Directors, announced today the appointment of Dr. Wilf
Keller as the new President and CEO of Genome Prairie.

"Dr. Keller's research experience, accomplishments and exemplary record of leadership at the National Research Council - Plant Biotechnology Institute make him the ideal choice for President and CEO," commented Dr. Naimark. Dr. Keller has held the position of Director of Research and, most recently, Acting Director General, at NRC-PBI.

Dr. Keller's appointment comes at a very important time for Genome Prairie. Genome Canada's Applied Genomics Research in Bioproducts and Crops (ABC) Competition is currently underway and involves several crops and bioproducts researchers in Saskatchewan and Manitoba. This competition creates an opportunity to bring a substantial amount of additional funding for genomics research to these provinces to advance agricultural production; and the use of renewable feedstocks for the production of bioproducts.

"Under the leadership of Jerome Konecsni, Genome Prairie has established itself as a prominent leader in development and implementation of genomics research projects in Manitoba and Saskatchewan", said Keller. "I am pleased to have the opportunity to work with Genome Prairie and look forward to facilitating further advances in genomics research and its applications in the prairie region and beyond."

Dr. Naimark also took the opportunity to acknowledge the work of current President and CEO, Jerome Konecsni.

"Jerome's leadership style, passion and commitment have established a firm foundation for future development based on effective collaboration regionally, nationally and internationally," said Naimark.

Mr. Konecsni will serve as President and CEO until June 30, 2008, at which time Dr. Ashley O'Sullivan will become acting President. Dr. Keller will assume full Presidential responsibilities on October 1, 2008.

Genome Prairie leads large-scale genomics and proteomics research projects in Manitoba and Saskatchewan. With its national and international partners, Genome Prairie has supported nearly $160 M of research activity in
plant, animal and human genomics, bioinformatics, instrumentation development and bioethics since 2000.
Through network establishment and regional priority consultations, Genome Prairie facilitates research linkages with funding from provincial governments, industry and Genome Canada - a not-for-profit organization implementing a national strategy in genomics and proteomics research to benefit all Canadians.

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved